Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events eu grants largest project safety evaluation drugs used treatment diabetes
… on projects to research rare diseases, rare disease treatment, and complications and comorbidities of rare … to treat rare diseases and complications arising from treatment of rare illnesses. Recent projects have included: … outcomes (PRO) studies (including instrument development, evaluation, and validation) Preparation of HTA and …
… scenario-based utility weights could also be used, along with the use of utility weights published in the … EQ-5D, or SF-6D. Methodological Guidelines: Economic Evaluation Guideline. Second Edition (Brazilian Ministry of … of New Product Assessment Form (NPAF) (SMC, 2022) EU HTA guidelines are listed per country in this chart …
45th European Cystic Fibrosis Society Conference Share on: Wednesday, June 8 - Sunday, June 12, 2022 Conference Website Research coauthored by RTI Health Solutions authors will be presented at the 45th European Cystic Fibrosis Society Conference. A …
15th European Public Health Conference 2022 (EPH) Share on: Wednesday, November 9 - Saturday, November 12, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 15th European Public Health Conference …
… View Now Generating and communicating evidence in COVID-19 treatment and vaccine development Although COVID-19-related … While companies race to be at the forefront of vaccine and treatment development, current strategies for evidence …
… this area uses cross-sectional analyses that offer only an evaluation of the data at individual time points and does not … for repeated measures, or MMRM – versus more commonly used cross-sectional methods based on an example data set … allowing for a more thorough examination including an evaluation of the statistical significance of the …
… and Risk Management Vaccines Psychiatry Men's Health Diabetes & Endocrine Disorders CNS/Neurology Headquarters - … using existing health care data to evaluate the use, safety, and effectiveness of pharmaceuticals, vaccines, and … multidatabase and multinational studies. He has been a project leader or scientific contributor within international …
Patient-Centered Outcomes Assessment Whether your goal is to support product claims, facilitate market access, or improve patient-clinician communication, our Patient-Centered Outcomes Assessment (PCOA) team provides a comprehensive set of services to …
… on HIV outcomes: a modeling study. Viguerie A, Jacobson EU, Hicks K, Bates L, Carrico J, Honeycutt A, Lyles C, …
… New Real-World Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share … Focus The study focused on patients who had received treatment with the MET inhibitor capmatinib, which gained … response rate as well as the duration of response, time-to-treatment discontinuation, disease control rate, and …